EP3795170
PHARMACEUTICAL COMPOSITION COMPRISING CCN5 AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING RETINAL DISEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.5.2019EP published:
20.3.2024EP application number:
19802765.8
EPO information:
European Patent Register
Max expiry date:
15.5.2039
Title in English:
PHARMACEUTICAL COMPOSITION COMPRISING CCN5 AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING RETINAL DISEASESLanguage of the patent:
English
Timeline
Today
16.5.2019EP application
20.3.2024EP Publication
Owner
Name:
Olives Biotherapeutics Inc.Address:
219-1ho, 123, Cheomdangwagi-ro Buk-gu, Gwangju 61005, KR
Inventor
Name:
PARK, Woo JinAddress:
Gwangju 61005, KR
Name:
YOON, AeriAddress:
Gwangju 61005, KR
Priority
Number:
20180056499Date:
17.5.2018Country:
KR
Classification
Categories:
A61K 38/18, A61K 39/395, A61K 31/7105, A61K 31/7088, A61K 35/12, A61K 35/28, A61K 35/30, A61K 35/545, A61K 35/76, A61P 27/02, C07K 16/22, C12N 15/86